Key Metrics
7.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
74
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.85
5-Year SI
5-year SI
- N/A 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Urology
SJR
- Q1 Urology
- Q1 Oncology
- Q1 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.72
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
32%
4 to 6 months
45%
7 to 9 months
20%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Prostate cancer
- Androgen deprivation therapy
- Overall survival
- Family history
- Odds ratio
- Resistance training
- Androgen
- Androgen receptor
- Quality of life
- Prostatectomy
- Prostate biopsy
- Enzalutamide
- Prostate-specific antigen
- Definitive radiotherapy
- Germline
- Erectile dysfunction
- Cryotherapy
- Clinical significance
- Body mass index
- Systematic review
Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Prostate Cancer and Prostatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysis.
- 20 Dec 24
- Prostate cancer and prostatic diseases
-
Full paper
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).
- 20 Dec 24
- Prostate cancer and prostatic diseases
-
Full paper
Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study.
- 18 Dec 24
- Prostate cancer and prostatic diseases
-
Full paper
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison.
- 7 Dec 24
- Prostate cancer and prostatic diseases
-
Full paper
Screening for homologous recombination genes.
- 6 Dec 24
- Prostate cancer and prostatic diseases
-
Full paper
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.
- 5 Dec 24
- Prostate cancer and prostatic diseases
Scite analysis
Powered by scite_
2.3k articles received 37.8k citations see all
- 1,657 Supporting
- 34,919 Mentioning
- 308 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 32 Corrections
- 53 Errata
- 0 Expression of Concern
FAQs
How long has Prostate Cancer and Prostatic Diseases been actively publishing?
Prostate Cancer and Prostatic Diseases has been in operation since 1997 till date.
What is the publishing frequency of Prostate Cancer and Prostatic Diseases ?
Prostate Cancer and Prostatic Diseases published with a Quarterly frequency.
How many articles did Prostate Cancer and Prostatic Diseases publish last years ?
In 2024, Prostate Cancer and Prostatic Diseases published 154 articles.
What is the eISSN & pISSN for Prostate Cancer and Prostatic Diseases ?
For Prostate Cancer and Prostatic Diseases,eISSN is 1476-5608 and pISSN is1365-7852.
What is Citescore for Prostate Cancer and Prostatic Diseases ?
Citescore for Prostate Cancer and Prostatic Diseases is 7.8.
What is H index for Prostate Cancer and Prostatic Diseases ?
H index for Prostate Cancer and Prostatic Diseases is 74.
What is SNIP score for Prostate Cancer and Prostatic Diseases ?
SNIP score for Prostate Cancer and Prostatic Diseases is 1.72.
What is the SJR for Prostate Cancer and Prostatic Diseases ?
SJR for Prostate Cancer and Prostatic Diseases is Q1.
Who is the publisher of Prostate Cancer and Prostatic Diseases ?
SPRINGERNATURE is the publisher of Prostate Cancer and Prostatic Diseases.